Letter to the Editor. Biomarker for delayed cerebral ischemia after aSAH

Restricted access

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Information

Contributor Notes

Correspondence Lu Ma: alex80350305@126.com.INCLUDE WHEN CITING Published online June 28, 2019; DOI: 10.3171/2019.1.JNS19186.Disclosures The authors report no conflict of interest.
Headings
References
  • 1

    Ding CYCai HPGe HLYu LHLin YXKang DZ: Assessment of lipoprotein-associated phospholipase A2 level and its changes in the early stages as predictors of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg [epub ahead of print January 18 2019; DOI: 10.3171/2018.8.JNS181839]

    • Search Google Scholar
    • Export Citation
  • 2

    Francoeur CLMayer SA: Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 20:2772016

  • 3

    Jabbarli RPierscianek DDarkwah Oppong MSato TDammann PWrede KH: Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev [epub ahead of print] 2018

    • Search Google Scholar
    • Export Citation
  • 4

    Rowland MJHadjipavlou GKelly MWestbrook JPattinson KT: Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109:3153292012

    • Search Google Scholar
    • Export Citation
  • 5

    Tao CWang JHu XMa JLi HYou C: Clinical value of neutrophil to lymphocyte and platelet to lymphocyte ratio after aneurysmal subarachnoid hemorrhage. Neurocrit Care 26:3934012017

    • Search Google Scholar
    • Export Citation
  • 6

    van Donkelaar CEDijkland SAvan den Bergh WMBakker JDippel DWNijsten MW: Early circulating lactate and glucose levels after aneurysmal subarachnoid hemorrhage correlate with poor outcome and delayed cerebral ischemia: a two-center cohort study. Crit Care Med 44:9669722016

    • Search Google Scholar
    • Export Citation
  • 1

    Dallmeier DKoenig W: Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2) and lipoprotein(a) (Lp(a)). Best Pract Res Clin Endocrinol Metab 28:2812942014

    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 90 90 90
Full Text Views 6 6 6
PDF Downloads 15 15 15
EPUB Downloads 0 0 0
PubMed
Google Scholar